BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23259638)

  • 1. Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
    Erdas E; Aste N; Pilloni L; Nicolosi A; Licheri S; Cappai A; Mastinu M; Cetani F; Pardi E; Mariotti S; Pomata M
    BMC Cancer; 2012 Dec; 12():614. PubMed ID: 23259638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
    Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
    J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.
    Keutgen XM; Nilubol N; Agarwal S; Welch J; Cochran C; Marx SJ; Weinstein LS; Simonds WF; Kebebew E
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):701-707. PubMed ID: 27464610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
    Cho YY; Chung YJ
    Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
    Omi Y; Horiuchi K; Haniu K; Tokura M; Nagai E; Isozaki O; Nagashima Y; Okamoto T
    Endocr J; 2018 Feb; 65(2):245-252. PubMed ID: 29225207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
    Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
    Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with MEN1: a case report.
    Liu Z; Zhao Y; Han X; Hu X; Zhang Y; Xu L; Chen G; Liu C; Xu S
    Front Endocrinol (Lausanne); 2023; 14():1175377. PubMed ID: 37795364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Thyroid Cancer in Patients with Multiple Endocrine Neoplasia Type 1 Undergoing Surgery for Primary Hyperparathyroidism.
    Hill KA; Yip L; Carty SE; McCoy KL
    Thyroid; 2019 Feb; 29(2):252-257. PubMed ID: 30608029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of multiple endocrine neoplasia type 1 and autoimmune disease: Coincidence or correlation?
    Chaves C; Nunes da Silva T; Dias Pereira B; Anselmo J; Claro I; Cavaco BM; Saramago A; Leite V
    Medicine (Baltimore); 2021 Dec; 100(49):e28145. PubMed ID: 34889280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.
    Murakami T; Usui T; Nakajima A; Mochida Y; Saito S; Nambu T; Kato T; Matsuda Y; Yonemitsu S; Muro S; Oki S
    Intern Med; 2015; 54(19):2475-81. PubMed ID: 26424307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor.
    Ishida E; Yamada M; Horiguchi K; Taguchi R; Ozawa A; Shibusawa N; Hashimoto K; Satoh T; Yoshida S; Tanaka Y; Yokota M; Tosaka M; Hirato J; Yamada S; Yoshimoto Y; Mori M
    Endocr J; 2011; 58(4):287-96. PubMed ID: 21441703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existence of glucagonoma with recurrent insulinoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1).
    Nishiuchi T; Imachi H; Murao K; Fujiwara M; Muraoka T; Kikuchi F; Nishiuchi Y; Kushida Y; Haba R; Ishida T
    Endocrine; 2009 Aug; 36(1):20-4. PubMed ID: 19350420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.
    Romero Arenas MA; Morris LF; Rich TA; Cote GJ; Grubbs EG; Waguespack SG; Perrier ND
    J Pediatr Surg; 2014 Apr; 49(4):546-50. PubMed ID: 24726110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.